Scott Mendel, President & CEO at GenMark Diagnostics, Inc. (GNMK), sold 3,751 shares at $9.52 ($36K) on 2020-05-28, disclosed to the SEC on 2020-06-01.
Open-market sale of $36k GNMK by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GNMK | SELL | 2021-01-25 | $1.8M | — | Filing → |
| GNMK | SELL | 2021-01-21 | $727K | — | Filing → |
| GNMK | SELL | 2020-11-25 | $137K | — | Filing → |